Lynne Glaser, RNP

NPI: 1275520694
Total Payments
$15,420
2024 Payments
$4,202
Companies
54
Transactions
761
Medicare Patients
1,042
Medicare Billing
$94,296

Payment Breakdown by Category

Food & Beverage$15,323 (99.4%)
Education$97.15 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,323 759 99.4%
Education $97.15 2 0.6%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,555 57 $0 (2024)
ABBVIE INC. $1,263 78 $0 (2024)
Amgen Inc. $1,197 49 $0 (2024)
Teva Pharmaceuticals USA, Inc. $1,027 87 $0 (2024)
Otsuka America Pharmaceutical, Inc. $930.49 32 $0 (2024)
PFIZER INC. $879.92 48 $0 (2024)
Neurocrine Biosciences, Inc. $630.54 36 $0 (2024)
Vanda Pharmaceuticals Inc. $620.92 26 $0 (2024)
Avanir Pharmaceuticals, Inc. $600.86 20 $0 (2022)
Janssen Pharmaceuticals, Inc $493.51 30 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,202 192 Otsuka America Pharmaceutical, Inc. ($490.71)
2023 $3,701 187 ABBVIE INC. ($402.78)
2022 $3,329 158 ABBVIE INC. ($420.93)
2021 $4,188 224 AstraZeneca Pharmaceuticals LP ($843.26)

All Payment Transactions

761 individual payment records from CMS Open Payments — Page 1 of 31

Date Company Product Nature Form Amount Type
12/17/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $22.84 General
Category: Bone Health
12/17/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $7.42 General
Category: Neuropsychiatry
12/16/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.24 General
Category: GASTROENTEROLOGY
12/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.38 General
Category: PSYCHIATRY
12/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $3.00 General
Category: PSYCHIATRY
12/10/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $20.78 General
Category: SCHIZOPHRENIA
12/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $4.81 General
Category: NEUROSCIENCE
12/05/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.56 General
Category: CNS
12/05/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $5.75 General
Category: Central Nervous System
12/03/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.18 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/02/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $22.04 General
Category: Cardiology/Vascular Diseases
12/02/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $5.94 General
Category: Neuropsychiatry
11/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $29.87 General
Category: PSYCHIATRY
11/21/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $5.88 General
Category: Central Nervous System
11/19/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $22.27 General
Category: Bone Health
11/18/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $24.49 General
Category: CNS
11/15/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $27.42 General
Category: Central Nervous System
11/12/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $27.48 General
Category: Inflammation
11/11/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $7.62 General
Category: SCHIZOPHRENIA
11/07/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $4.94 General
Category: Central Nervous System
11/05/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $19.32 General
Category: Cardiology/Vascular Diseases
11/05/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $4.01 General
Category: PSYCHIATRY
11/04/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.55 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/29/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $114.40 General
Category: Neuropsychiatry
10/29/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.86 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 279 756 $112,175 $39,501
2022 4 232 434 $60,351 $20,851
2021 3 227 420 $39,813 $16,559
2020 3 304 496 $42,244 $17,384
Total Patients
1,042
Total Services
2,106
Medicare Billing
$94,296
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Office 2023 202 585 $81,970 $27,575 33.6%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Office 2023 39 129 $22,575 $9,276 41.1%
99305 Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes Office 2023 24 24 $6,000 $2,188 36.5%
99307 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes Office 2023 14 18 $1,630 $461.38 28.3%
99308 Follow-up nursing facility visit per day, typically 15 minutes Office 2022 174 349 $43,200 $14,403 33.3%
99309 Follow-up nursing facility visit per day, typically 25 minutes Office 2022 29 56 $9,800 $3,483 35.5%
99306 Initial nursing facility visit per day, typically 45 minutes Office 2022 16 16 $4,160 $1,818 43.7%
99305 Initial nursing facility visit per day, typically 35 minutes Office 2022 13 13 $3,191 $1,146 35.9%
99308 Subsequent nursing facility visit, typically 15 minutes per day Office 2021 152 333 $33,325 $14,440 43.3%
99307 Subsequent nursing facility visit, typically 10 minutes per day Office 2021 62 67 $4,288 $1,400 32.6%
99335 Established patient assisted living visit, typically 25 minutes Office 2021 13 20 $2,200 $719.68 32.7%
99308 Subsequent nursing facility visit, typically 15 minutes per day Office 2020 154 244 $24,400 $9,530 39.1%
99307 Subsequent nursing facility visit, typically 10 minutes per day Office 2020 131 226 $14,464 $6,622 45.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 19 26 $3,380 $1,233 36.5%

About Lynne Glaser, RNP

Lynne Glaser, RNP is a Nurse Practitioner healthcare provider based in Cumberland, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275520694.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lynne Glaser, RNP has received a total of $15,420 in payments from pharmaceutical and medical device companies, with $4,202 received in 2024. These payments were reported across 761 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,323).

As a Medicare-enrolled provider, Glaser has provided services to 1,042 Medicare beneficiaries, totaling 2,106 services with total Medicare billing of $94,296. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Cumberland, RI
  • Active Since 09/30/2005
  • Last Updated 04/25/2014
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1275520694

Products in Payments

  • ELIQUIS (Drug) $1,042
  • NUEDEXTA (Drug) $750.59
  • VRAYLAR (Drug) $732.10
  • Otezla (Drug) $713.35
  • FARXIGA (Drug) $703.97
  • REXULTI (Drug) $699.57
  • INGREZZA (Drug) $623.55
  • AUSTEDO (Drug) $597.16
  • CAPLYTA (Drug) $587.68
  • XARELTO (Drug) $463.84
  • LOKELMA (Drug) $425.29
  • Austedo XR (Drug) $388.20
  • JARDIANCE (Drug) $329.65
  • HETLIOZ (Drug) $328.36
  • UBRELVY (Drug) $302.61
  • FANAPT (Drug) $292.56
  • Repatha (Biological) $285.21
  • ARISTADA (Drug) $270.07
  • Kerendia (Drug) $254.22
  • BREZTRI (Drug) $236.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Cumberland